85 related articles for article (PubMed ID: 16652376)
1. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.
Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC
Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376
[TBL] [Abstract][Full Text] [Related]
2. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
[TBL] [Abstract][Full Text] [Related]
3. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
[TBL] [Abstract][Full Text] [Related]
4. PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.
Gu S; Chen L; Hong Q; Yan T; Zhuang Z; Wang Q; Jin W; Zhu H; Wu J
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):771-8. PubMed ID: 21831961
[TBL] [Abstract][Full Text] [Related]
5. Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer.
Xia WY; Lien HC; Wang SC; Pan Y; Sahin A; Kuo YH; Chang KJ; Zhou X; Wang H; Yu Z; Hortobagyi G; Shi DR; Hung MC
Breast Cancer Res Treat; 2006 Aug; 98(3):295-301. PubMed ID: 16752078
[TBL] [Abstract][Full Text] [Related]
6. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin.
Hesselbrock DR; Kurpios N; Hassell JA; Watson MA; Fleming TP
Breast Cancer Res Treat; 2005 Feb; 89(3):289-96. PubMed ID: 15754128
[TBL] [Abstract][Full Text] [Related]
7. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
[TBL] [Abstract][Full Text] [Related]
8. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Colomer R; Lupu R
J Natl Cancer Inst; 2005 Nov; 97(21):1611-5. PubMed ID: 16264182
[TBL] [Abstract][Full Text] [Related]
9. Activation of the WT1 tumor suppressor gene promoter by Pea3.
Discenza MT; Vaz D; Hassell JA; Pelletier J
FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
[TBL] [Abstract][Full Text] [Related]
10. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
12. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
13. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
Baert JL; Monté D; Musgrove EA; Albagli O; Sutherland RL; de Launoit Y
Int J Cancer; 1997 Mar; 70(5):590-7. PubMed ID: 9052761
[TBL] [Abstract][Full Text] [Related]
14. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.
Bièche I; Tozlu S; Girault I; Onody P; Driouch K; Vidaud M; Lidereau R
Carcinogenesis; 2004 Mar; 25(3):405-11. PubMed ID: 14633660
[TBL] [Abstract][Full Text] [Related]
15. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
Kumar R; Neilsen PM; Crawford J; McKirdy R; Lee J; Powell JA; Saif Z; Martin JM; Lombaerts M; Cornelisse CJ; Cleton-Jansen AM; Callen DF
Cancer Res; 2005 Dec; 65(24):11304-13. PubMed ID: 16357137
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
18. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
19. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis.
Xing X; Wang SC; Xia W; Zou Y; Shao R; Kwong KY; Yu Z; Zhang S; Miller S; Huang L; Hung MC
Nat Med; 2000 Feb; 6(2):189-95. PubMed ID: 10655108
[TBL] [Abstract][Full Text] [Related]
20. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
